Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;42(3):396-401.
doi: 10.1097/MAO.0000000000002943.

Cochlear Implantation and Electric Acoustic Stimulation in Children With TMPRSS3 Genetic Mutation

Affiliations

Cochlear Implantation and Electric Acoustic Stimulation in Children With TMPRSS3 Genetic Mutation

Jourdan T Holder et al. Otol Neurotol. .

Abstract

Background: Mutations in the TMPRSS3 gene, although rare, can cause high frequency hearing loss with residual hearing at low frequencies. Several previous studies have reported cochlear implant (CI) outcomes for adults with TMPRSS3 mutation with mixed results. Although some studies have suggested that TMPRSS3 is expressed in spiral ganglion cells, it remains unclear if previously reported poor CI outcomes in this population were secondary to long durations of deafness or to the effects of the TMPRSS3 mutation. To date, no studies in the literature have reported CI outcomes for children with TMPRSS3 mutation treated with CI.

Objective: The current case series aimed to describe outcomes for three children with sloping hearing loss caused by TMPRSS3 mutation who underwent bilateral CI.

Study design: Case series.

Setting: Academic medical center.

Patients: Three children (3-4 yr) with TMPRSS3 mutation and normal sloping to profound high frequency hearing loss.

Interventions: CI and electric acoustic stimulation (EAS).

Main outcome measures: Outcome measures were residual hearing thresholds, speech recognition scores, and electrode placement determined via intraoperative CT imaging.

Results: All three children maintained residual acoustic hearing and received benefit from EAS. Mean change in low-frequency pure-tone average was 17 dB. Mean postoperative word and sentence recognition scores in the bilateral EAS condition were 80 and 75%, respectively.

Conclusions: Results indicate that CI with EAS is an appropriate treatment for children with TMPRSS3 genetic mutation. Pediatric results from this case series show more favorable CI outcomes than are currently reported for adults with TMPRSS3 mutation suggesting that the intervention may be time sensitive.

PubMed Disclaimer

Conflict of interest statement

Conflict(S) of Interest to Declare: None directly related to this case series.

Figures

FIG. 1.
FIG. 1.
Preoperative and postoperative residual hearing thresholds as well as aided detection thresholds are shown for the A) Patient 1, B) Patient 2, and C) Patient 3.

References

    1. Camp GV, Willems PJ, Smith RJ. Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 1997;60:758–64. - PMC - PubMed
    1. Battelino S, Klancar G, Kovac J, Battelino T, Trebusak Podkrajsek K. TMPRSS3 mutations in autosomal recessive nonsyndromic hearing loss. Eur Arch Otorhinolaryngol 2016;273:1151–4. - PubMed
    1. Wattenhofer M, Di Iorio M, Rabionet R, et al. Mutations in the TMPRSS3 gene are a rare cause of childhood nonsyndromic deafness in Caucasian patients. J Mol Med 2002;80:124–31. - PubMed
    1. Scott HS, Kudoh J, Wattenhofer M, et al. Insertion of β-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet 2001;27:59–63. - PubMed
    1. Guipponi M, Toh MY, Tan J, et al. An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing loss. Hum Mutat 2008;29:130–41. - PubMed

Publication types